UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:February 08,
Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Phio Pharmaceuticals Charts.
Phio Pharmaceuticals (NASDAQ:PHIO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Phio Pharmaceuticals Charts.

Phio Pharmaceuticals Corp. News

Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
Monday 22 April 2024 (6 days ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Thursday 11 April 2024 (2 weeks ago) • GlobeNewswire Inc.
National Spotlight Features Phio’s Innovative RNAi Technology Platform
Wednesday 3 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Tuesday 2 April 2024 (4 weeks ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Thursday 21 March 2024 (1 month ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Wednesday 6 March 2024 (2 months ago) • GlobeNewswire Inc.
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 20 February 2024 (2 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Wednesday 31 January 2024 (3 months ago) • GlobeNewswire Inc.

More Phio Pharmaceuticals Corp. News Articles